If cell-specific or spatially localized excitation is present, extrinsically increasing GLT-1 levels before ALS end-stage may increase glutamate reuptake, thereby prolonging survival or minimally prolonging muscle function after ALS onset. The gene discussed is SLC1A2; the disease is amyotrophic lateral sclerosis.